Similarly, inhibition of ACLY with bempedoic acid reduces lipid droplet accumulation and fibrosis in mouse models of diet-induced non-alcoholic fatty liver disease (Morrow et al., 2022). Here, ACLY is linked to metabolic dysfunction-associated steatotic liver disease.